The Global Multiple Sclerosis Drugs Market size was valued at USD 27.47 Billion in 2020 and is projected to reach USD 42.46 Billion in 2028, growing at a CAGR of 6% from 2022-2028. Multiple sclerosis (MS) is the most common neurological disorder that causes disability. Multiple sclerosis is classified as an autoimmune, chronic and inflammatory disease of the central […]
